A novel therapeutic compound, tolfenamic acid, inhibits ovarian cancer cell growth: Therapeutic implications

Overview

cited authors

Basha, Riyaz M., Ingersoll, Susan B., Sankpal, Umesh T., Ahmad, Sarfraz, Edwards, John R., Holloway, Robert W., Kaja, Sumanth, Abdelrahim, Maen

authors

Ahmad, Sarfraz, PhD, FAACC; FABAP
Holloway, Robert W., MD

Publication Date

April 15, 2011

webpage

Web of Science

published in

CANCER RESEARCH Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.